" Receptor Radionuclide Therapy With 177Lu-DOTATOC

Conditions:   Neuroendocrine Tumors;   Paraganglioma;   Pheochromocytoma Intervention:   Drug: 177Lu-DOTATOC Sponsor:   Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials